🫀 DOES ANNULOPLASTY RING SIZE AFFECT LONG-TERM MITRAL REPAIR DURABILITY?
📚 Our study found an association between larger annuloplasty ring sizes and an increased risk of late failure following degenerative mitral valve repair. @LHSCCanada @MichaelMwachu @MohsynM @mathieuR.
📢 New publication!
Our meta-analysis of 2,064 patients found comparable long-term outcomes between subcoronary and full-root techniques in the Ross procedure.
Grateful to Dr. @MichaelMwachu and all co-authors for this collaboration! @JoacoGundelach @AAlfabeto61437
W Samir Cubas retweeted
In Memoriam: Dominique Vervoort, MD, MPH, MBA (1994-2026) - CJC Open cjcopen.ca/article/S2589-790… 💔🙏
🚨 New Publication
Pleased to share our latest systematic review and meta-analysis on homografts versus prosthetic valves in destructive aortic endocarditis. Grateful to Drs. @MichaelMwachu, @JonathanHongMD, @AAlfabeto61437 @JoacoGundelach @Satoshi_Arimura @Yasuhiko
🚀 Excited to share our recent publication: The Evolution of MICS Literature: A 50-Year North American Bibliometric Review and Future Trends.
🙏 Grateful to the @LHSCCanada team 🇨🇦
@MichaelMwachu @AAlfabeto61437
onlinelibrary.wiley.com/doi/…
#CardiovascularSurgery #MICS #Research
💯💥📢New publication: Global bibliometric analysis of the Ross procedure (1967–2025).
2,370 papers, sustained growth, and a strong future trajectory toward 2050.
@MichaelMwachu
@LHSCCanada @SchulichMedDent
🔗doi.org/10.1177/021849232614…
#CardiovascularSurgery #RossProcedure
Go ahead 🤩 Thanks a lot💯💫💥 @AATSHQ @AATSJournals @LATAM_LACES
@MichaelMwachu @VictorDayan1 @ggsoca @loremontesvilla @santiago_cubas @max_hernandez26 @JoacoGundelach
Presenting now and newly published in #JTCVS: Machine Learning Predicts Postoperative Mortality in a Latin American Cardiovascular Surgery Multicenter Cohort: Toward Precision Risk Stratification. Michael W A Chu, @WildorSamir, Victor Dayán, et. Al. Read: doi.org/10.1016/j.jtcvs.2026…
W Samir Cubas retweeted
You are replaceable at work, but you are NOT replaceable at home. A beautiful and poignant reflection that applies to all clinicians.
W Samir Cubas retweeted
Los Peruanos - new article has been published on Medium
medium.com/p/3443d360f21d?po…
#math
😪
The world has lost a shining light.
@DVervoort94 walked this world with grace, compassion, and a deep passion for health equity.
We are heartbroken to have lost Dom and are grieving with his family and all those around the world who knew him and loved him.
Honored to serve as a STS 2026 Social Media Ambassador 🫀🇨🇦🇵🇪
📢 2 posters (Mitral Valve & Yang Technique) from our LHSC🇨🇦 team
🎛1 oral presentation-Homografts in destructive aortic endocarditis.
Grateful and excited for this outstanding scientific meeting. @STS_CTsurgery – at New Orleans, LA
STS 2026 Social Media Ambassadors📢.
@STS_CTsurgery
We’re excited to announce the STS 2026 Social Media Ambassadors!
They’ll be sharing key takeaways, sessions, and moments from the Annual Meeting—so be sure to follow along using #STS2026.
@ShandaBlackmon @SinaDaneshMD @WagemakerSofia @wildorsamir @umar_nasir2k
🔬🫀 Publication Alert🇨🇦🇵🇪🇦🇷
PMEGs vs t-BRANCH device for complex thoracoabdominal/paravisceral aneurysms (2020–2024)
📊 51 patients | Overall mortality 9.8%
🏥 In-hospital mortality: t-BRANCH 23.1% vs PMEGs 5.3%
⚠️ Mortality predictors: ASA IV, prior stroke @RogerCardiaca
W Samir Cubas retweeted
A concise umbrella review on SAVR vs TAVR that highlights how nuanced decision-making has become in aortic stenosis @WildorSamir. Beautiful job!
STS/EACTS/LACES 2025 🇵🇪 — Honoured to present four abstracts, including our first and impactful global umbrella review on TAVR vs. SAVR (n=526,189 patients/Low-risk). 📊✨
Thanks to my mentors, team, and colleagues 🙏✨
1️⃣ TAVR’s early edge fades; SAVR favours after ~3.5 years ⏳❤️🩹
2️⃣ Industry-funded studies show more positive TAVR results 🔍📚
True TAVR superiority—or just bias and industry influence? ⚖️🔍 @MichaelMwachu @JoacoGundelach @VictorDayan1 @ggsoca @loremontesvilla @EACTS @STS_CTsurgery @LATAM_LACES
🎓 Honoured to have completed the Global Clinical Scholars Research Training (GCSRT) at Harvard Medical School – Class of 2025 🇺🇸.
My capstone ranked in the top third, marking a year of research, global networking, and growth. Grateful to my family, friends, and mentors 🌍🙏
Fantastic @LATAM_LACES 🇵🇪 webinar on “Surgical Approach for Aortic Arch Reconstruction”🫀
Thanks to Dr. @MichaelMwachu 🇨🇦 for the excellent presentation, and to Dr.Ramos 👩⚕️ & Dr. @calebriosortega 👨⚕️ for their invaluable contributions. @RMSSAA @VictorDayan1 @loremontesvilla






































